CLINICAL_TRIALS
trial_result
· 2018-02-23
Clinical Trial Update: A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men [Phase 3]
Summary
Phase 3 trial of oral testosterone undecanoate in men with hypogonadism completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clarus Therapeutics, Inc. | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-02-23